UBS Group’s Athenahealth, Inc. ATHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1,361,834
| Closed | -$180M | – | 8567 |
|
|
2018
Q4 | $180M | Buy |
1,361,834
+1,321,106
| +3,244% | +$169M | 0.08% | 235 |
|
|
2018
Q3 | $5.44M | Buy |
40,728
+13,692
| +51% | +$2.05M | ﹤0.01% | 2270 |
|
|
2018
Q2 | $4.3M | Buy |
27,036
+2,232
| +9% | +$331K | ﹤0.01% | 2469 |
|
|
2018
Q1 | $3.55M | Buy |
24,804
+6,967
| +39% | +$952K | ﹤0.01% | 2623 |
|
|
2017
Q4 | $2.37M | Sell |
17,837
-6,041
| -25% | -$772K | ﹤0.01% | 3044 |
|
|
2017
Q3 | $2.97M | Buy |
23,878
+8,328
| +54% | +$1.15M | ﹤0.01% | 2730 |
|
|
2017
Q2 | $2.19M | Buy |
15,550
+6,756
| +77% | +$844K | ﹤0.01% | 2935 |
|
|
2017
Q1 | $991K | Buy |
8,794
+4,115
| +88% | +$480K | ﹤0.01% | 3537 |
|
|
2016
Q4 | $492K | Buy |
4,679
+3,754
| +406% | +$404K | ﹤0.01% | 4134 |
|
|
2016
Q3 | $117K | Buy |
925
+118
| +15% | +$15K | ﹤0.01% | 4906 |
|
|
2016
Q2 | $111K | Sell |
807
-315
| -28% | -$41.7K | ﹤0.01% | 4957 |
|
|
2016
Q1 | $156K | Buy |
1,122
+422
| +60% | +$57.9K | ﹤0.01% | 4671 |
|
|
2015
Q4 | $113K | Hold |
700
| – | – | ﹤0.01% | 5124 |
|
|
2015
Q3 | $93K | Hold |
700
| – | – | ﹤0.01% | 5296 |
|
|
2015
Q2 | $80K | Hold |
700
| – | – | ﹤0.01% | 5593 |
|
|
2015
Q1 | $84K | Sell |
700
-408
| -37% | -$54.4K | ﹤0.01% | 5567 |
|
|
2014
Q4 | $161K | Buy |
+1,108
| New | +$139K | ﹤0.01% | 5250 |
|
UBS Group's ATHN Position: Q1 2019 in Review
UBS Group sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 1,361,834 shares — an estimated $180M sold.
UBS Group first reported a position in ATHN in Q4 2014 and held it in 17 quarters. The position peaked at $180M in Q4 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.
- UBS Group reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
- UBS Group sold 1,361,834 Athenahealth, Inc. shares in Q1 2019, an estimated $180M.
- UBS Group first reported a position in Athenahealth, Inc. in Q4 2014 and held it in 17 quarters.
- UBS Group's Athenahealth, Inc. position peaked at $180M in Q4 2018.
- 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.
Based on UBS Group's 13F filing for Q1 2019, filed 14 May 2019.